AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1,358 Cr | ₹1,290 Cr | ₹311 Cr | ₹159 Cr | ₹158 Cr |
What is the latest Contingent Liabilities ratio of AUROBINDO PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹1,358 Cr |
| Mar2025 | ₹1,290 Cr |
| Mar2024 | ₹311 Cr |
| Mar2023 | ₹159 Cr |
| Mar2022 | ₹158 Cr |
How is Contingent Liabilities of AUROBINDO PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,358 Cr | 5.28 | |
| Mar2025 | ₹1,290 Cr | 314.42 | |
| Mar2024 | ₹311 Cr | 96.39 | |
| Mar2023 | ₹159 Cr | 0.50 | |
| Mar2022 | ₹158 Cr | - | |
Compare Contingent Liabilities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹90,697.4 Cr | -5.1% | -9.2% | 43.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -0.2% | -4.9% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,904.0 Cr | 1.3% | -2.3% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹172,213.0 Cr | -1.5% | -5.8% | 29.3% | Stock Analytics | |
| CIPLA | ₹106,138.0 Cr | 0.1% | -4.2% | -14.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,304.0 Cr | 1.9% | 5.7% | 0.4% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -5.1% |
-9.2% |
43.8% |
| SENSEX | 0.9% |
-0.8% |
-10.5% |
You may also like the below Video Courses